Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

The Handbook of Tuberculosis: Molecular Biology and Biochemistry is an Essential Resource to Molecular and Cell Biologists, Bacteriologists, Immunologists, Pathologists and Pathophysiologists

Posted on: Tuesday, 5 February 2008, 09:00 CST

Research and Markets (http://www.researchandmarkets.com/reports/c81782) has announced the addition of Handbook of Tuberculosis: Molecular Biology and Biochemistry to their offering.

Tuberculosis (TB), a deadly airborne disease caused by the bacterium Mycobacterium tuberculosis, takes the lives of almost 2 million people each year and is considered to be the most common infectious disease in the world. However, thanks to the efforts of researchers such as the volumes' lead editor, Dr. Stefan H. E. Kaufmann, there have been several recent advances in fighting the disease.

Dr. Stefan Kaufmann, the Founding Director of the Max Planck Institute for Infection Biology in Berlin and Professor of Microbiology and Immunology at the Charité at the Humboldt University, Berlin, has published more than 600 scientific articles and currently serves as President of the European Federation of Immunological Societies and Chair of the Immunology Division of the American Society of Microbiology. Dr. Kaufmann is considered the world's leading expert in the field of tuberculosis.

The Handbook of Tuberculosis, which explores the causes and available treatments of the widespread infection as well as current research into vaccination, is divided into three separate volumes covering different areas of study. Each volume provides an essential resource to molecular and cell biologists, bacteriologists, immunologists, pathologists and pathophysiologists, clinicians and those working in the pharmaceutical industry and interested in world health.

Volume 1: Molecular Biology and Biochemistry highlights the molecular mechanisms of tuberculosis. The book is co-edited by Dr. Eric Rubin, Professor of Immunology and Infectious Diseases at the Harvard School of Public Health. It provides the basis for the three-volume set by focusing on the genomic and genetic nature of the pathogen as well as current medical advancements that combat the bacterium on a molecular level.

Volume 2: Immunology and Cell Biology presents the pre-eminent resource for all aspects of cell biology and immunology of tuberculosis, including vaccine development.

Volume 3: Clinics, Diagnostics, Therapy and Epidemiology introduces a comprehensive overview of clinical aspects of tuberculosis, including drug resistance, epidemiological aspects and clinical trials.

Author Info:

Prof. Dr. Stefan H.E. Kaufmann is Founding Director of the Max Planck Institute for Infection Biology, Berlin. He has published more than 600 scientific articles and is member of numerous scientific societies and committees e.g. current President of the European Federation of Immunological Societies, and Chair of the Immunology division of the American Society of Microbiology. He has won numerous prestigious awards including the Scientific Prize of Smith Kline Beecham and the Pettenkofer Prize.

Eric Rubin is Professor of Immunology and Infectious Diseases at the Harvard School of Public Health. He carried out both his MD and PhD work at Tufts University.

Content Outline:

Molecular Genetics and Biochemistry: Introduction

Biochemistry of the Cell Wall

Glycolipids and Polyketides of M. tuberculosis

Physiology of M. tuberculosis

Nutrient Transport

Iron Uptake by M. tuberculosis

Protein Transport

PE and PPE Gene Family Members in M. tuberculosis

Virulence/Persistence Mechanisms of M. tuberculosis

Genomics

Transcriptomics and Transcriptional Regulation

Proteomics of M. tuberculosis

Structure

Molecular Mechanisms of Dormancy and Resuscitation

M. tuberculosis in the Phagosome

Molecular Mechanisms of Drug Resistance of M. tuberculosis

Experimental Genetics of M. tuberculosis

Molecular Evolution of Mycobacteria

For more information visit http://www.researchandmarkets.com/reports/c81782


Source: Business Wire

More News in this Category


Related Articles



Rating: 2.7 / 5 (9 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required